Systems pharmacology analysis of oncology drug combinations to evaluate adverse events due to drug-drug interactions

被引：0
|
作者：
Kim, Sarah [1 ]
Lahu, Gezim [2 ]
Lesko, Lawrence J. [1 ]
Trame, Mirjam N. [1 ]
机构：
[1] Univ Florida, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
[2] Takeda Pharmaceut Int GmbH, Zurich, Switzerland
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-68
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [1] Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions
    Brown, Joshua D.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [2] Probability analysis on associations of adverse drug events with drug-drug interactions
    Huang, Yu-Ting
    Lin, Shih-Fang
    Chiu, Chung-Cheng
    Yeh, Hsiang-Yuan
    Sooi, Von-Wun
    PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, 2007, : 1308 - +
  • [3] Reducing harms: Focus on drug-drug interactions and adverse drug events
    Citrome, Leslie
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (10)
  • [4] AN EXEMPLAR OF A SYSTEMS PHARMACOLOGY APPROACH FOR A DETAILED INVESTIGATION OF AN ADVERSE DRUG EVENT AS A RESULT OF DRUG-DRUG INTERACTIONS
    Kim, S.
    Lahu, G.
    Lesko, L. J.
    Trame, M. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S97 - S97
  • [5] Editorial: Drug-drug interactions in pharmacology
    Pichini, Simona
    Di Trana, Annagiulia
    Garcia-Algar, Oscar
    Busardo, Francesco Paolo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Systems Pharmacology: Defining the Interactions of Drug Combinations
    van Hasselt, J. G. Coen
    Iyengar, Ravi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59, 2019, 59 : 21 - 40
  • [7] Safety pro file of nirmatrelvir-ritonavir: Evidence of adverse events due to drug-drug interactions
    Gonzalez-Gomez, Alvaro
    Caro-Teller, Jose Manuel
    Gonzalez-Barrios, Ivan
    Castro-Frontinan, Almudena
    Rodriguez-Quesada, Pedro Pablo
    Ferrari-Piquero, Jose Miguel
    FARMACIA HOSPITALARIA, 2024, 48 (02) : 70 - 74
  • [8] Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
    Martocchia, Antonio
    Spuntarelli, Valerio
    Aiello, Francesco
    Meccariello, Anna Laura
    Proietta, Maria
    Del Porto, Flavia
    Di Rosa, Roberta
    Salemi, Simonetta
    March, Massimiliano Rocchietti
    Lagana, Bruno
    Martelletti, Paolo
    Sesti, Giorgio
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (03) : 243 - 249
  • [9] Drug-drug interactions in pediatric oncology patients
    Balk, T. E.
    van der Sijs, I. H.
    van Gelder, T.
    Janssen, J. J. B.
    van der Sluis, I. M.
    van Leeuwen, R. W. F.
    Engels, F. K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)
  • [10] Clinically relevant drug-drug interactions in oncology
    McLeod, HL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (06) : 539 - 544
12345